TrialHuman vaccines & immunotherapeutics2024

Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial.

Diana Alexandra Echeverria Proano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.